News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Men who have sex with men (MSM) news

Show

From To
Ethnic and cultural minorities
HIV hitting Latino men in California at an alarming rate

“One in four Latino men in the Valley in 2020 who have sex with men will test positive for HIV in their lifetimes,” said Oscar Lopez, vice president of policy, advocacy, education and communication for the Valley AIDS Council. Lopez just returned from the 2019 NHPC Hispanic/Latin MSM and Trans Latina Meeting with the CDC in Atlanta. Latino leaders met to discuss a plan of action in response to staggering numbers released in October by the CDC.

Published
01 April 2019
From
The Monitor
Men who have sex with men (MSM)
Arizona sued over 'No Promo Homo' school sex-ed curriculum

Two gay-rights organizations are suing Arizona over its so-called "No Promo Homo" law, which bans public district and charter school HIV/AIDS instruction that "promotes a homosexual lifestyle."

Published
29 March 2019
From
AZ Central
PrEP programmes and uptake
On the legacy of AIDS — trauma and shame get in the way of HIV prevention

The generational divide that erupted in San Francisco during this forum about pre-exposure prophylaxis motivated me to study how men of different generations think about sex, health and PrEP. It also motivated me to get on PrEP — a decision that changed my life.

Published
29 March 2019
From
San Francisco Chronicle
Hepatitis C transmission and prevention
Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men

Incidence of acute hepatitis C virus (HCV) among men who have sex with men (MSM) who use pre-exposure prophylaxis (PrEP) in Lyon increased tenfold between

Published
29 March 2019
By
Michael Carter
PrEP programmes and uptake
My PrEP Story: Phil (part 3)

There is not enough research specifically on black queer men and what the motivations and barriers are for us accessing or not accessing PrEP. Charlie Witzel, a research fellow from London School of Hygiene and Tropical Medicine lead a new study on this to find out how to design specifically targeted programs and services that help black queer men to take PrEP

Published
27 March 2019
From
Prepster
PrEP programmes and uptake
Young Black Men at Risk for HIV Underestimate Threat

A study that started out looking at HIV risk behaviors and substance use turned into an opportunity for researchers to examine what it would take for young black men who have sex with men to try pre-exposure prophylaxis (PrEP) and stay on it.

Published
12 March 2019
From
Medscape (requires free registration)
Retention and linkage to care
India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

Based out of the Humsafar Trust’s office jn Mumbai, the centre will give free counselling and provide Anti-Retroviral Therapy (ART) to the LGBTQ community. TAshok Row Kavi, founder chairperson of the Trust, said: “Until now we would get testing done for the community members at our centre. If tested positive for the disease, they would be asked to go to Sion Hospital, but there was a huge dropout (rate) there. Because of how the community is perceived outside, a lot of these people wouldn’t seek treatment."

Published
12 March 2019
From
Hindustan Times
PrEP programmes and uptake
People stay on PrEP for 14 months on average in the US, study finds

Whether HIV pre-exposure prophylaxis (PrEP) is effective depends on whether people take it appropriately, at the times when they are at risk of HIV. But we know

Published
10 March 2019
By
Gus Cairns
PrEP science
How many people who have used PrEP get HIV the same year? New York study finds out

One question often asked about pre-exposure prophylaxis (PrEP) use is how frequently people start PrEP while unknowingly having HIV, often because they have acquired it so recently

Published
07 March 2019
By
Gus Cairns
PrEP science
Descovy is non-inferior to Truvada for daily PrEP

A daily pill containing the newer formulation of tenofovir in combination with emtricitabine (Descovy) had a comparable protective effect to the existing daily pill which contains the older

Published
06 March 2019
By
Roger Pebody
← Prev1...34567...189Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.